Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_1949
http://purl.obolibrary.org/obo/dinto_1949
|
|---|---|
| Preferred Name | dna polymerase epsilon subunit 3 |
| Synonyms |
astp
chrac-17
arsenic-transactivated protein
huchrac17
dna polymerase ii subunit 3
dna polymerase epsilon subunit p17
chromatin accessibility complex 17
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | dna polymerase epsilon subunit 3
|
|---|---|
| label | dna polymerase epsilon subunit 3
|
| Definition | Forms a complex with DNA polymerase epsilon subunit CHRAC1 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome-remodeling activity of ISWI/SNF2H and ACF1
|
| type | |
| is inhibited by | |
| Synonym |
astp
chrac-17
arsenic-transactivated protein
huchrac17
dna polymerase ii subunit 3
dna polymerase epsilon subunit p17
chromatin accessibility complex 17
See more
See less
|
| OrganismClass | human
|
| xref |
UniProt ID:Q9NRF9
DrugBank:6112
|
| definition source | DrugBank Database
|
| prefixIRI | obo2:dinto_1949
|
| is pharmacological target of | |
| Gene | pole3
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |